实用肝脏病杂志 ›› 2020, Vol. 23 ›› Issue (6): 901-904.doi: 10.3969/j.issn.1672-5069.2020.06.036

• 肝癌 • 上一篇    下一篇

肝移植患者凝血功能和血栓弹力图指标动态变化*

王广耕, 李茜, 王姗, 霍霓, 许进明, 张林海   

  1. 222000 江苏省连云港市第二人民医院输血科(王广耕,李茜,王姗,霍霓,张林海);
    南京医科大学第一附属医院输血科(许进明)
  • 收稿日期:2020-07-05 发布日期:2021-02-25
  • 通讯作者: 张林海,E-mail:zlh302@126.com
  • 作者简介:王广耕,男,29岁,大学本科
  • 基金资助:
    *江苏省自然科学基金资助项目(编号:2008152)

Dynamic changes of thromboelastography and coagulation function parameters before and after liver transplantation and its significance for guidance of blood transfusion

Wang Guanggeng, Li Qian, Wang Shan, et al   

  1. Department of Blood Transfusion, Second People's Hospital, Lianyungang 222000,Jiangsu Province, China
  • Received:2020-07-05 Published:2021-02-25

摘要: 目的 研究肝移植患者血栓弹力图(TEG)和凝血功能指标的变化及其对输血的指导意义。方法 2018年3月~2020年3月在我院治疗的52例肝移植患者,比较无肝前期、无肝期和新肝期输血和未输血患者TEG指标,如反应时间(R)、血块形成时间(K)、角度(α)、最大振幅(MA)和凝血功能指标,如凝血酶原时间(PT)、活化部分凝血酶时间(APTT)、凝血酶时间(TT)和纤维蛋白原(Fib)的变化。结果 在52例患者中,无肝前期输血率为17.3%,无肝期输血率为86.5%,新肝期输血率为75.0%(P<0.05);无肝前期输血患者APTT为(74.4±7.2)s,显著长于未输血患者【(66.9±8.1)s,P<0.05】,新肝期输血患者PT和TT分别为(30.4±5.4)s和(30.2±3.6)s,显著长于未输血患者【分别为(26.1±4.6)s和(27.0±4.2)s,P<0.05】,无肝期输血与未输血患者APTT、PT、TT和Fib水平无显著性差异(P>0.05);无肝前期输血患者K值为(7.6±1.8)min,显著长于未输血者【(6.0±2.0)min,P<0.05】,无肝期输血患者R、K和α分别为(26.4±5.5)min、(15.3±2.8)min和(15.8±4.4)°,未输血者分别为(21.8±4.3)min、(12.0±3.9)min和(19.5±3.9)°,两组间差异均有统计学意义(P<0.05);新肝期输血患者α和MA分别为(20.3±4.1)°和(34.4±5.8)mm,未输血者分别为(23.8±3.5)°和(39.0±4.5)mm,两组间差异有统计学意义(P<0.05);无肝前期20例大量输血患者APTT为(77.3±6.8)s,显著长于32例未大量输血患者的【(70.4±7.9)s,P<0.05】,无肝前期大量输血患者K值为(8.0±1.7)min,显著长于未大量输血患者【(7.1±1.4)min,P<0.05】,无肝期大量输血患者R值为(29.3±5.2)min,显著长于未大量输血患者【(23.6±4.7)min,P<0.05】,无肝期大量输血患者K值为(16.8±3.1)min,显著长于未大量输血患者【(13.7±2.8)min,P<0.05】,无肝期α为(15.2±3.6)°,显著小于未大量输血患者【(18.4±4.4)°,P<0.05】,新肝期大量输血患者TT水平为(31.5±3.0)s,显著长于未大量输血患者【(28.2±3.3)s,P<0.05】,新肝期大量输血患者MA水平为(32.8±5.5)mm,显著短于未大量输血患者【(38.7±4.3)mm,P<0.05】,新肝期大量输血患者α为(19.8±3.7)°,显著小于未大量输血患者【(22.4±3.1)°,P<0.05】。结论 对于肝移植患者及时动态地监测TEG和凝血功能指标有助于判断凝血功能变化,指导合理地输血,各指标的意义还需要认真地研究。

关键词: 肝移植, 血栓弹力图, 凝血功能指标, 输血

Abstract: Objective The aim of this study was to investigate the dynamic changes of thromboelastography (TEG) and coagulation function parameters before and after liver transplantation and its significance for guidance of blood transfusion. Methods 52 patients with benign and malignant liver diseases underwent liver transplantation between March 2018 and March 2020, and the TEG indexes, such as reaction time (R), clot formation time (k), angle (α), maximum amplitude (MA) and four items of coagulation functions such as prothrombin time (PT), activated partial thrombin time (APTT), thrombin time (TT) and fibrinogen (FIB) were monitored in patients at pre-without liver, without liver and new liver stages. Results Out of our 52 recipients of liver transplantation, 17.3%, 86.5% and 75.0%(P<0.05) of them received blood transfusion at pre-without liver, without liver and new liver stage; the APTT in patients with blood transfusion at pre-without liver stage was(74.4±7.2) s, significantly longer than 【(66.9±8.1)s, P<0.05】 in patients without blood transfusion, the PT and TT in recipients with blood transfusion at new liver stage were(30.4±5.4)s and (30.2±3.6)s, significantly longer than 【(26.1±4.6)s and (27.0±4.2)s, P<0.05 in those without blood transfusion, while the APTT, PT, TT and Fib in patients with or without blood transfusion at without liver stage were not much different(P>0.05); the K value in patients with bloodtransfusion at without liver stage was (7.6±1.8)min, significantly longer than 【(6.0±2.0)min, P<0.05】 in those without blood transfusion, the R, K andα in patients with blood transfusion at without liver stage were(26.4±5.5)min, (15.3±2.8)min and (15.8±4.4)°, while they were(21.8±4.3)min, (12.0±3.9)min and (19.5±3.9)°, respectively,in those without blood transfusion, showing significantly different between the two groups(P<0.05); the α and MA in patients with blood transfusion at new liver stage were(20.3±4.1)° and (34.4±5.8)mm, significantly different compared to(23.8±3.5)° and (39.0±4.5)mm in patients without blood transfusion(P<0.05); the APTT in 20 patients with huge blood transfusion at pre-without liver stage was(77.3±6.8)s, significantly longer than【(70.4±7.9)s, P<0.05】 in 32 patients without huge blood transfusion, the K in patients with huge blood transfusion at pre-without liver stage was (8.0±1.7)min, significantly longer than 【(7.1±1.4)min, P<0.05】 in those without huge blood transfusion, the R in patients with huge blood transfusion at without liver stage was (29.3±5.2)min, significantly longer than 【(23.6±4.7)min, P<0.05】 in those without huge blood transfusion, the K in patients with huge blood transfusion atwithout liver stage was (16.8±3.1)min, much longer than【(13.7±2.8)min, P<0.05】in those without huge blood transfusion, the α at without liver stage was (15.2±3.6)°, significantly smaller than【(18.4±4.4)°, P<0.05】 in those without huge blood transfusion, the TT in patients with huge blood transfusion at new liver stage was(31.5±3.0)s, significantly longer than 【(28.2±3.3)s, P<0.05】 in those without huge blood transfusion, the MA at new liver stage was(32.8±5.5)mm, significantly shorter than 【(38.7±4.3)mm, P<0.05】 in those without huge blood transfusion, and theα at new liver stage was (19.8±3.7)°, significantly smaller than【(22.4±3.1)°, P<0.05】 in patients without huge blood transfusion. Conclusion The dynamic surveillance of four items of coagulation functions and TEG parameters are helpful to judge the coagulation function state andcould guide the clinicians for appropriate blood transfusion before and after liver transplantation, especially the dynamic monitoring of R and α values of TEG are helpful to predict the risk of massive blood transfusion during operation.

Key words: Liver transplantation, Thromboelastogram, Coagulation functions, Blood transfusion